Collegium Pharmaceutical (COLL) Stock Chart & Stock Price History $30.15 -0.41 (-1.34%) As of 03/25/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Collegium Pharmaceutical Stock Price Performance 5 Day Performance+0.33%1 Month Performance+6.35%3 Month Performance+2.24%6 Month Performance-21.63%Year-To-Date Performance+5.24%1 Year Performance-24.49% Receive COLL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address COLL Stock Chart for Wednesday, March, 26, 2025 COLL Chart by TradingViewRemove Ads Collegium Pharmaceutical Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/25/2025$30.56$30.15-1.34%$30.46$29.96212,158 shs$949.30 million03/24/2025$30.05$30.56+1.70%$30.84$29.42556,260 shs$962.21 million03/21/2025$29.93$30.05+0.40%$30.53$29.252.29 million shs$946.15 million03/20/2025$29.85$29.93+0.27%$30.01$29.38413,289 shs$942.38 million03/19/2025$29.82$29.85+0.10%$30.00$29.42256,839 shs$939.86 million03/18/2025$29.67$29.82+0.51%$29.86$29.28333,477 shs$938.91 million03/17/2025$29.46$29.67+0.71%$29.78$28.58288,189 shs$934.19 million03/14/2025$29.10$29.46+1.24%$30.01$29.01388,648 shs$927.58 million03/13/2025$29.63$29.10-1.79%$29.91$28.94271,093 shs$916.24 million03/12/2025$29.99$29.63-1.20%$29.91$29.02487,663 shs$932.93 million Get the Latest News and Ratings for COLL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 03/11/2025$29.66$29.99+1.11%$30.04$29.03455,016 shs$944.27 million03/10/2025$28.91$29.66+2.59%$29.89$28.37388,231 shs$933.88 million03/07/2025$29.80$28.91-2.99%$30.01$28.76382,217 shs$910.26 million03/06/2025$28.47$29.80+4.67%$30.02$28.18439,919 shs$938.28 million03/05/2025$28.04$28.47+1.53%$28.52$27.28477,852 shs$896.41 million03/04/2025$28.44$28.04-1.41%$28.61$27.70461,957 shs$904.29 million03/03/2025$29.05$28.44-2.10%$29.63$28.13379,925 shs$917.19 million02/28/2025$28.42$29.05+2.22%$31.44$28.81697,752 shs$936.86 million02/27/2025$28.35$28.42+0.25%$29.00$27.84636,112 shs$916.55 million02/26/2025$28.82$28.35-1.63%$29.50$28.31355,128 shs$914.29 million02/25/2025$29.19$28.82-1.27%$29.40$28.52464,839 shs$929.45 million Related Companies SWTX Stock Chart RARE Stock Chart AKRO Stock Chart ALVO Stock Chart IMVT Stock Chart VKTX Stock Chart RYTM Stock Chart SRRK Stock Chart CRNX Stock Chart MRUS Stock Chart Receive COLL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:COLL) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
